Plasma IL-1 Receptor Antagonist Concentration Has an Inverse Association With Birth Weight in Prepubertal Children

Henrikki Nordman1, Raimo Voutilainen1, Leena Antikainen1

  • 1Department of Pediatrics, University of Eastern Finland and Kuopio University Hospital, FI-70211 Kuopio, Finland.

Insights

Children born small for gestational age (SGA) have higher inflammation markers, while those born large for gestational age (LGA) have lower levels. This suggests SGA children may face greater future metabolic risks.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Inflammation Research

Background:

  • Birth size is linked to future cardiometabolic risk, often mediated by low-grade inflammation.
  • Interleukin-1 receptor antagonist (IL-1ra) is a key inflammatory marker.

Purpose of the Study:

  • To investigate plasma IL-1ra levels in relation to birth size (SGA, appropriate, LGA) in prepubertal children.
  • To examine associations between IL-1ra and cardiometabolic/inflammatory markers.

Main Methods:

  • A cohort study involving 5-8 year old children categorized by birth size (SGA, n=23; appropriate, n=56; LGA, n=49).
  • Collected anthropometric data and analyzed plasma IL-1ra, alanine transaminase, lipids, glucose, 25-hydroxyvitamin D, and high-sensitivity C-reactive protein (hs-CRP).

Main Results:

  • Plasma IL-1ra concentrations, adjusted for BMI SDS, were highest in SGA-born and lowest in LGA-born children (P=0.015).
  • IL-1ra showed strong associations with BMI SDS (P<0.001) and hs-CRP (P<0.001), even after BMI adjustment.

Conclusions:

  • Prepubertal SGA children exhibited higher IL-1ra levels, while LGA children had lower levels.
  • The strong association between IL-1ra and hs-CRP, independent of BMI, suggests a heightened inflammatory state in SGA children.
  • SGA children may be at increased risk for later metabolic disturbances due to this inflammatory profile.
Abstract

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
641
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.1K
Antiasthma Drugs: Muscarinic Receptor Antagonists01:20

Antiasthma Drugs: Muscarinic Receptor Antagonists

Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.8K
Adrenergic Antagonists: &#593; and &#946;-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.4K
Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
6.9K